Veracyte Inc (Veracyte) is a diagnostics company that uses genomic technology to resolve diagnostic ambiguity. the company offers products such as Afirma, Percepta, Envisia, Prosigna, Lymphmark and Decipher. Its products are used in therapeutic areas such as thyroid, prostate, breast, bladder, lung cancers and interstitial lung diseases. Veracyte also provides vitro diagnostics (IVD) services including manufacturing, quality control, assay and process transfer, supply chain and other services to biopharmaceutical and diagnostics companies. The company operates in the US, France and Israel. Veracyte is headquartered in San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Veracyte Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
Veracyte Inc Company Overview
Veracyte Inc Company Snapshot
Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
Veracyte Inc – Pipeline Analysis Overview
Veracyte Inc - Key Facts
Veracyte Inc - Major Products and Services
Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Ongoing Clinical Trials by Trial Status
Veracyte Inc Pipeline Products Overview
Afirma - Risk of Recurrence
Afirma - Risk of Recurrence Product Overview
Afirma - Thyroid Cancer Staging/ Prognosis Test
Afirma - Thyroid Cancer Staging/ Prognosis Test Product Overview
AI Based Liquid Biopsy Assay - Solid Tumors Product Overview
BronchoGen Test
BronchoGen Test Product Overview
C2inform MRD Test
C2inform MRD Test Product Overview
C2inform MRD Test Clinical Trial
Comprehensive Genomic Profiling Test
Comprehensive Genomic Profiling Test Product Overview
Decipher Prostate Biopsy Test
Decipher Prostate Biopsy Test Product Overview
Decipher Prostate Biopsy Test Clinical Trial
Decipher Prostate RP Assay
Decipher Prostate RP Assay Product Overview
Diagnostic Assay - Renal Cancer
Diagnostic Assay - Renal Cancer Product Overview
Disease Diagnosis Device
Disease Diagnosis Device Product Overview
Envisia - Disease Progression Test
Envisia - Disease Progression Test Product Overview
Envisia - Rx Response Test
Envisia - Rx Response Test Product Overview
Envisia Genomic Classifier
Envisia Genomic Classifier Product Overview
Envisia IVD Test
Envisia IVD Test Product Overview
nCounter Dx LymphMark Assay
nCounter Dx LymphMark Assay Product Overview
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test Product Overview
Percepta Atlas
Percepta Atlas Product Overview
Percepta Nasal Swab Test
Percepta Nasal Swab Test Product Overview
Percepta Nasal Swab Test Clinical Trial
Prosigna NGS Test
Prosigna NGS Test Product Overview
Veracyte Inc - Key Competitors
Veracyte Inc - Key Employees
Veracyte Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Veracyte Inc, Recent Developments
Jun 03, 2024: Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
May 22, 2024: Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
May 07, 2024: Veracyte Announces First Quarter 2024 Financial Results
May 06, 2024: 14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease Understanding
Apr 22, 2024: New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Apr 16, 2024: Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Feb 27, 2024: Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines
Dec 01, 2023: Real-World Data Presented at SUO 2023 Show that Veracyte’s Decipher Genomic Classifier Identifies Patients Whose Prostate Cancer is Likely to Progress
Nov 29, 2023: Clinical Validation Data Published in CHEST Demonstrate that Veracyte’s Percepta Nasal Swab Test Improves Lung Cancer Risk Assessment for Patients with Lung Nodules
Nov 22, 2023: Veracyte Announces Seven Posters Highlighting Clinical Value of Decipher Prostate Genomic Testing To be Presented at SUO 2023
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Veracyte Inc Pipeline Products and Ongoing Clinical Trials Overview
Veracyte Inc Pipeline Products by Equipment Type
Veracyte Inc Pipeline Products by Indication
Veracyte Inc Ongoing Clinical Trials by Trial Status
Veracyte Inc, Key Facts
Veracyte Inc, Major Products and Services
Veracyte Inc Number of Pipeline Products by Development Stage
Veracyte Inc Pipeline Products Summary by Development Stage
Veracyte Inc Ongoing Clinical Trials by Trial Status
Veracyte Inc Ongoing Clinical Trials Summary
Afirma - Risk of Recurrence - Product Status
Afirma - Risk of Recurrence - Product Description
Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Status
Afirma - Thyroid Cancer Staging/ Prognosis Test - Product Description
Afirma Xpression Atlas - Pulmonology - Product Status
AI Based Liquid Biopsy Assay - Solid Tumors - Product Status
AI Based Liquid Biopsy Assay - Solid Tumors - Product Description
BronchoGen Test - Product Status
BronchoGen Test - Product Description
C2inform MRD Test - Product Status
C2inform MRD Test - Product Description
C2inform MRD Test - Multi-Institutional Evaluation of C2i-Test Performance for Detecting Molecular Residual Disease (MRD) in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy
Comprehensive Genomic Profiling Test - Product Status
Comprehensive Genomic Profiling Test - Product Description
Decipher Prostate Biopsy Test - Product Status
Decipher Prostate Biopsy Test - Product Description
Decipher Prostate Biopsy Test - A Validation Study on the Impact of Decipher Testing on Treatment Recommendations in African-american and Non-african American Men with Prostate Cancer (VANDAAM Study)
Decipher Prostate Biopsy Test - Genomics in Michigan to Adjust Outcomes in Prostate Cancer (G-MAJOR): A Randomized Multi-center Study for Men with Newly Diagnosed Favorable Risk Prostate Cancer
Decipher Prostate RP Assay - Product Status
Decipher Prostate RP Assay - Product Description
Diagnostic Assay - Renal Cancer - Product Status
Diagnostic Assay - Renal Cancer - Product Description
Disease Diagnosis Device - Product Status
Disease Diagnosis Device - Product Description
Envisia - Disease Progression Test - Product Status
Envisia - Disease Progression Test - Product Description
Envisia - Rx Response Test - Product Status
Envisia - Rx Response Test - Product Description
Envisia Genomic Classifier - Product Status
Envisia Genomic Classifier - Product Description
Envisia IVD Test - Product Status
Envisia IVD Test - Product Description
nCounter Dx LymphMark Assay - Product Status
nCounter Dx LymphMark Assay - Product Description
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Status
nCounter FLEX Analysis System - Idiopathic Pulmonary Fibrosis Test - Product Description
Percepta Atlas - Product Status
Percepta Atlas - Product Description
Percepta Nasal Swab Test - Product Status
Percepta Nasal Swab Test - Product Description
Percepta Nasal Swab Test - Clinical Utility of Management of Patients With CT and LDCT Identified Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Prosigna NGS Test - Product Status
Prosigna NGS Test - Product Description
Veracyte Inc, Key Employees
Veracyte Inc, Subsidiaries
Glossary
List of Figures
Veracyte Inc Pipeline Products by Equipment Type
Veracyte Inc Pipeline Products by Development Stage
Veracyte Inc Ongoing Clinical Trials by Trial Status